Key Data Points

Primary metrics and data points about Geron Corp.
Current Price: $2.47
Prev Close: $2.47
Open: $2.49
Bid: $2.44
Ask: $2.48
Day's Range: $2.38 - $2.54
52wk Range: $1.27 - $7.79
Volume: 2,290,243
Avg Vol 3,868,359
Market Cap: $388M
P/E (ttm): -9.15
EPS (ttm): ($0.27)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Geron Corp.

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drugs

Stock Charting

GERN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Geron Corp.
CAPS Rating 2 out of 5
 
619 Outperform
60 Underperform
CAPS All Stars
 
91 Outperform
17 Underperform

Will GERN beat the market?

Powered by Motley Fool CAPS


More Details about Geron Corp

Primary metrics and data points about Geron Corp.

Company Photos

Powered by